Milk-derived extracellular vesicles — very small, natural particles from cow’s milk — were shown to safely reduce inflammation and scarring…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
In people with diffuse cutaneous systemic sclerosis (dcSSc), certain skin features, including levels of specific molecules and cells, depend…
More than a third of adults with systemic sclerosis (SSc) who develop interstitial lung disease (ILD) see their condition…
Researchers in China have identified five genes — COL1A2, COL3A1, COL15A1, THY-1, and CCL19 — that may play a key…
Galderma is launching a Phase 2 clinical trial to test nemolizumab, an antibody the company is developing to ease…
Levels of certain types of immune cells are abnormally high in some people with systemic sclerosis (SSc), and this…
Adicet Bio expects adults with systemic sclerosis (SSc) soon to start enrolling in its ongoing Phase 1…
The presence of different autoantibodies specific to systemic sclerosis (SSc) can determine how the disease is likely to progress…
Immunosuppressive medications may help to reduce inflammation in the heart and the overall burden of primary heart involvement that is…
The CCL2 gene, which codes for a signaling protein of the same name, is “a common characteristic gene” of both…